How Data and Technology Platforms Can Improve Diversity in Clinical Trials and Clinical Research

Life sciences companies continue to face obstacles when efficiently designing and conducting diverse clinical trials and clinical research.  Recorded on 1/26/22, PurpleLab's CMIO, Russell Robbins, joined with Medable, Veradigm, and Datavant showed how innovative data and technology platforms can improve diversity in clinical trials and clinical research.

WATCH NOW

* Your information is safe with us. We hate SPAM too.

In the webinar, the speakers discussed efficient ways to improve diversity, including the ability to:

  • Understand the complex connection between social determinants of health (SDOH), disease burden and health outcomes
  • Uncover meaningful social risk factors from electronic health records and point of care systems
  • Remotely recruit, source, screen and enroll patients through decentralized trials platforms
SDOH_4[5]

Presenter: Russell Robbins

Chief Medical Informations Officer, PurpleLab

Russell D. Robbins, MD, MBA is the Chief Medical Information Officer at PrupleLab. He is responsible for the HealthNexus platform’s clinical rules and development of new modules. Dr. Robbins is a nationally recognized thought leader on episodes of care having spent over twenty years working on and developing a variety of healthcare groupers on physician efficiency and quality. He has lectured on this topic both domestically as well as internationally.

Russell